a experimental cancer drug 
that work after a single round of treatment appear to be the most effective medicine yet for a rare form of leukemia, 
the drug _ call 2-chlorodeoxyadenosine, or 2-cda _ 
have produce complete remission in almost all hairy cell leukemia patient treated, and none have relapse so far 
the drug also have be use successfully against chronic lymphocytic leukemia 
accord to a study 
researcher 
the medicine report, like hairy cell leukemia, be a cancer of the white blood 
who develop and test the medicine report 
cells, 
Scripps recently make a agreement with Johnson & Johnson's Ortho Pharmaceuticals 